TB-001

N/A

Report date: 2024/06/04 16:17:13
NME

Base Information

Drug NameTB-001
Drug Alias NameTB001TB-001
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionGlucagon receptor agonistsGlucagon-like peptide 1 receptor agonists
TargetsGlucagon receptorGlucagon-like peptide 1 receptor
Therapy Area/IndicationsLiver CirrhosisMetabolic Dysfunction-Associated Steatotic Liver DiseaseCholangitis, Sclerosing +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesShenzhen Turier Biotech Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesQingyuan Tuwei Anchuang Technology Development Co LtdShenzhen Turier Biotech Co Ltd
Inactive CompaniesN/A
Active IndicationsLiver CirrhosisMetabolic Dysfunction-Associated Steatotic Liver DiseaseCholangitis, Sclerosing +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A